COVID-19 / Lessons from MSD’s Ebola Vaccine Development: Balancing Ambition with Reality
While outbreaks of the devastating Ebola virus have – thankfully – generally been highly localized to West…
Karen Xi |
Editor
Articles: Karen Xi
China / The Pharma Deals Keep Coming
The latest from Chinese pharma, with dealmaking continuing apace. Featured this week are Zai Lab’s latest IPO…
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
Asia-Pacific / Pharma Partnerships News September 2020
The latest news from Asia-Pacific pharma, including Alovtech and DKSH’s biosimilar commercialisation partnership,…
Biosimilar Adoption in the USA / Still Lagging Behind Europe
As part of our upcoming US Healthcare and Life Sciences Review, we spoke to key stakeholders – former Association…
Gilead's Remdesivir / No Overnight Success Story
With remdesivir practically a household name today as the first therapeutic to be approved for the treatment of…
Chinese Biotech Strategies / Biologics or Small Molecules
While the vast majority of the global pharma market still comprises small molecule drugs, the biologics sector has…
Chinese Biotech Strategies / The Pros & Cons of In-Licensing
Since the Chinese biopharma boom started in the late-2000s, Chinese biotechs have seen in-licensing as a shortcut…
US Biotech Commercialisation Strategies / How Karyopharm & Ionis Are Approaching US vs ROW
With US still the reigning global champion in biotech innovation, the dynamic and vibrant biopharma ecosystem in…
COVID-19 in Latin America / News Roundup September 2020
The latest from the fight against COVID-19 in Latin America, including J&J’s vaccine trials, issues…
IFPMA / Global Pharma Execs Hail ‘Unprecedented’ Speed & Collaboration of COVID-19 Response
During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media…
Canada / Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt…